TW FB IG

Eng

No products in the cart.

Home / Human Rights / China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL

China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL

December 14, 2023 by Lezzie 0 comments Human Rights

China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL

Innovative drugs VALTOCO (Diazepam Nasal Spray)ï¼ŒILUMETRI (Tildrakizumab Injection) and rare disease drug Tetrabenazine Tablets have been newly included in China’s National Reimbursement Drug List(NRDL), XinHuoSu (Recombinant Human Brain Natriuretic Peptide for Injection) has continued to be included in NRDL.- China Medical System actively responds to national policies to promote innovative products to be included in the NRDL…
Read More

PREVConcourt ruling on asylum seekers welcomed by human rights groups

NEXTPH votes for UN resolution seeking immediate Gaza ceasefire